Ogawa Koji 小川浩司

… Alternative Names

koji ogawa 小川浩司

Less

Researcher Number	20735188
Other IDs
Affiliation (based on the past Project Information) *help	2020 – 2022: 北海道大学, 大学病院, 助教 2015 – 2017: 北海道大学, 大学病院, 助教
Review Section/Research Field	Principal Investigator Basic Section 53010:Gastroenterology-related / Gastroenterology
Keywords	Principal Investigator バイオマーカー / NAFLD / 糖鎖マーカー / 肝線維化 / 糖鎖 / NASH / カルニチン / 肝脂肪化 / HCV

Glycan Modification Analysis as a Novel Diagnostic Marker and Therapeutic Target for Non-Alcoholic Fatty Liver DiseasePrincipal Investigator
- Principal Investigator
  
  Ogawa Koji
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Hokkaido University
Anti-Adipogenic and Antiviral Effects of L-Carnitine on Hepatitis C Virus InfectionPrincipal Investigator
- Principal Investigator
  
  koji ogawa
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Hokkaido University

All 2023 2022 2021 2020 2018 2017 2016 2015

All Journal Article Presentation

[Journal Article] Serum Angiopoietin-2 Predicts the Occurrence and Recurrence of Hepatocellular Carcinoma after Direct-Acting Antiviral Therapy for Hepatitis C2023
- Author(s)
  Kawagishi Naoki、Suda Goki、Yamamoto Yoshiya、Baba Masaru、Furuya Ken、Maehara Osamu、Ohnishi Shunsuke、Yoshida Sonoe、Fu Qingjie、Yang Zijian、Hosoda Shunichi、Tokuchi Yoshimasa、Kitagataya Takashi、Ohara Masatsugu、Suzuki Kazuharu、Nakai Masato、Sho Takuya、Natsuizaka Mitsuteru、Ogawa Koji、Sakamoto Naoya
- Journal Title
  
  Viruses
  
  Volume: 15 Issue: 1 Pages: 181-181
- DOI
  10.3390/v15010181
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08046, KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-20K17008, KAKENHI-PROJECT-23K24311
[Journal Article] Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation‐related hepatitis2023
- Author(s)
  Suda Goki、et al.,
- Journal Title
  
  Journal of Medical Virology
  
  Volume: 95 Issue: 2
- DOI
  10.1002/jmv.28452
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K08046, KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-20K17008
[Journal Article] Changes in Serum Growth Factors during Resistance to Atezolizumab Plus Bevacizumab Treatment in Patients with Unresectable Hepatocellular Carcinoma2023
- Author(s)
  Yang Zijian、Suda Goki、Maehara Osamu、Ohara Masatsugu、Yoda Tomoka、Sasaki Takashi、Kohya Risako、Yoshida Sonoe、Hosoda Shunichi、Tokuchi Yoshimasa、Kitagataya Takashi、Suzuki Kazuharu、Kawagishi Naoki、Nakai Masato、Sho Takuya、Natsuizaka Mitsuteru、Ogawa Koji、Ohnishi Shunsuke、Sakamoto Naoya
- Journal Title
  
  Cancers
  
  Volume: 15 Issue: 3 Pages: 593-593
- DOI
  10.3390/cancers15030593
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-20K17039
[Journal Article] Hepatitis C virus eradication by direct‐acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low‐density lipoprotein cholesterolemia without an increase in body weight2023
- Author(s)
  Tokuchi Yoshimasa、Sho Takuya et al.,
- Journal Title
  
  Hepatology Research
  
  Volume: in press Issue: 7 Pages: 595-606
- DOI
  10.1111/hepr.13899
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K07953, KAKENHI-PROJECT-22K08046, KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-20K17008, KAKENHI-PROJECT-23K24311
[Journal Article] Serum IL-1β predicts de novo hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C, not during anti-cancer/immunosuppressive therapy2022
- Author(s)
  Kawagishi Naoki、Suda Goki et al.,
- Journal Title
  
  Scientific Reports
  
  Volume: 12 Issue: 1
- DOI
  10.1038/s41598-022-21315-z
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08046, KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-20K17008
[Journal Article] Changes in the estimated renal function after hepatitis C virus eradication with direct-acting antiviral agents: Impact of changes in skeletal muscle mass2021
- Author(s)
  Tokuchi Y, Suda G, Kimura M, Maehara O, Kitagataya T, Ohara M, Yamada R, Shigesawa T, Suzuki K, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N.
- Journal Title
  
  J Viral Hepat.
  
  Volume: in press Issue: 5 Pages: 755-763
- DOI
  10.1111/jvh.13484
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-21K07953, KAKENHI-PROJECT-20K17008
[Journal Article] Baseline elevated serum angiopoietin-2 predicts long-term non-regression of liver fibrosis after direct-acting antiviral therapy for hepatitis C2021
- Author(s)
  Kawagishi Naoki、Suda Goki、Kimura Megumi、Maehara Osamu、Yamada Ren、Tokuchi Yoshimasa、Kubo Akinori、Kitagataya Takashi、Shigesawa Taku、Suzuki Kazuharu、Ohara Masatsugu、Nakai Masato、Sho Takuya、Natsuizaka Mitsuteru、Morikawa Kenichi、Ogawa Koji、Kudo Yusuke、Nishida Mutsumi、Sakamoto Naoya
- Journal Title
  
  Scientific Reports
  
  Volume: 11 Issue: 1 Pages: 9207-9207
- DOI
  10.1038/s41598-021-88632-7
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K21592, KAKENHI-PROJECT-19H03630, KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-21K07953, KAKENHI-PROJECT-20K17008
[Journal Article] Characteristics and Lenvatinib Treatment Response of Unresectable Hepatocellular Carcinoma with Iso-High Intensity in the Hepatobiliary Phase of EOB-MRI2021
- Author(s)
  Kubo Akinori、Suda Goki、Kimura Megumi、Maehara Osamu、Tokuchi Yoshimasa、Kitagataya Takashi、Ohara Masatsugu、Yamada Ren、Shigesawa Taku、Suzuki Kazuharu、Kawagishi Naoki、Nakai Masato、Sho Takuya、Natsuizaka Mitsuteru、Morikawa Kenichi、Ogawa Koji、Ohnishi Shunsuke、Sakamoto Naoya
- Journal Title
  
  Cancers
  
  Volume: 13 Issue: 14 Pages: 3633-3633
- DOI
  10.3390/cancers13143633
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-21K07953, KAKENHI-PROJECT-20K17008, KAKENHI-PROJECT-20K17039
[Journal Article] Possible correlation between increased serum free carnitine levels and increased skeletal muscle mass following HCV eradication by direct acting antivirals2021
- Author(s)
  Tokuchi Yoshimasa、Suda Goki、et al.,
- Journal Title
  
  Scientific Reports
  
  Volume: 11 Issue: 1 Pages: 16616-16616
- DOI
  10.1038/s41598-021-96203-z
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K21592, KAKENHI-PROJECT-19H03630, KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-20K08371
[Journal Article] Serum fatty acid-binding protein 5 is a significant factor in hepatocellular carcinoma progression independent of tissue expression level2021
- Author(s)
  Ohira Masafumi、Yokoo Hideki、Ogawa Koji、Fukai Moto、Kamiyama Toshiya、Sakamoto Naoya、Taketomi Akinobu
- Journal Title
  
  Carcinogenesis
  
  Volume: 42 Issue: 6 Pages: 794-803
- DOI
  10.1093/carcin/bgab025
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K08298
[Journal Article] Time-dependent changes in the seroprevalence of COVID-19 in asymptomatic liver disease outpatients in an area in Japan undergoing a second wave of COVID-192020
- Author(s)
  Suda G, Ogawa K, Kimura M, Maehara O, Kitagataya T, Ohara M, Tokuchi Y, Kubo A, Yamada R, Shigesawa T, Suzuki K, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Sakamoto N.
- Journal Title
  
  Hepatol Res.
  
  Volume: 5- Issue: 10 Pages: 1196-1200
- DOI
  10.1111/hepr.13551
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-20K08371
[Journal Article] Analysis of the optimal psoas muscle mass index cut-off values, as measured by computed tomography, for the diagnosis of loss of skeletal muscle mass in Japanese people.2020
- Author(s)
  Ohara M, Suda G, Kimura M, Maehara O, Shimazaki T, Shigesawa T, Suzuki K, Nakamura A, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Kobayashi T, Uebayashi M, Takagi R, Yokota I, Shimamura T, Sakamoto N.
- Journal Title
  
  Hepatol Res
  
  Volume: in press Issue: 6 Pages: 715-725
- DOI
  10.1111/hepr.13499
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-18K19530, KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-20K08371
[Journal Article] Prevalence, clinical course, and predictive factors of immune checkpoint inhibitor monotherapy-associated hepatitis in Japan.2020
- Author(s)
  Kitagataya T, Suda G, Nagashima K, Katsurada T, Yamamoto K, Kimura M, Maehara O, Yamada R, Shigesawa T, Suzuki K, Nakamura A, Ohara M, Umemura M, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Ohnishi S, Komatsu Y, Hata H, Takeuchi S, Abe T, Sakakibara-Konishi J, Teshima T, Homma A, Sakamoto N.
- Journal Title
  
  J Gastroenterol Hepatol
  
  Volume: in press Issue: 10 Pages: 1782-1788
- DOI
  10.1111/jgh.15041
- NAID
  120007160309
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K08298
[Journal Article] Safety and efficacy of sofosbuvir and ribavirin for genotype 2 hepatitis C Japanese patients with renal dysfunction2018
- Author(s)
  Sho T, Suda G,, Nagasaka A, Yamamoto Y, Furuya K, Kumagai K, Uebayashi M, Terashita K, Kobayashi T, Tsunematsu I, Onodera M, Meguro T, Kimura M, Ito J, Umemura M, Izumi T, Kawagishi N, Ohara M, Ono Y, Nakai M, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N
- Journal Title
  
  Heptology Research
  
  Volume: in press Issue: 7 Pages: 529-538
- DOI
  10.1111/hepr.13056
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K09334, KAKENHI-PROJECT-16H05282, KAKENHI-PROJECT-15K08980, KAKENHI-PROJECT-16K15420
[Journal Article] Treatment of hepatitis C in special populations.2018
- Author(s)
  Suda G, Ogawa K, Morikawa K, Sakamoto N
- Journal Title
  
  Journal of Gastroenterology
  
  Volume: in press Issue: 5 Pages: 591-605
- DOI
  10.1007/s00535-017-1427-x
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K09334, KAKENHI-PROJECT-16H05282, KAKENHI-PROJECT-15K08980
[Journal Article] Increased serum C-reactive protein and decreased urinary aquaporin 2 levels are predictive of the efficacy of tolvaptan in patients with liver cirrhosis.2018
- Author(s)
  3.Nakai M, Ogawa K, Takeda R, Ohara M, Kawagishi N, Izumi T, Umemura M, Ito J, Sho T, Suda G, Morikawa K, Sakamoto N
- Journal Title
  
  Hepatology Research
  
  Volume: in press
- NAID
  120006551584
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K08980
[Journal Article] Retreatment with sofosbuvir, ledipasvir, and add-on ribavirin for patients who failed daclatasvir and asunaprevir combination therapy2017
- Author(s)
  Suda G, Ogawa K, Yamamoto Y, Katagiri M, Furuya K, Kumagai K, Konno J, Kimura M, Kawagishi N, Ohara M, Umemura M, Ito J, Izumi T, Nakai M, Sho T, Natsuizaka M, Morikawa K, Tsubota A, Shimada N, Iio E, Tanaka Y, Sakamoto N; NORTE Study Group.
- Journal Title
  
  J Gastroenterol
  
  Volume: 印刷中 Issue: 10 Pages: 1122-1129
- DOI
  10.1007/s00535-017-1328-z
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26461021, KAKENHI-PROJECT-15K08980, KAKENHI-PROJECT-16K09334, KAKENHI-PROJECT-15K06810, KAKENHI-PROJECT-16K15420
[Journal Article] Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus infected patients with renal impairment2017
- Author(s)
  Suda G, Nagasaka A, Yamamoto Y, Furuya K, Kumagai K, Kudo M, Terashita K, Kobayashi T, Tsunematsu I, Yoshida J, Meguro T, Kimura M, Ito J, Umemura M, Izumi T, Tsunematsu S, Sato F, Tsukuda Y, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N; NORTE Study Group.
- Journal Title
  
  Hepatol Res
  
  Volume: 印刷中 Issue: 11 Pages: 1127-1136
- DOI
  10.1111/hepr.12851
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26461021, KAKENHI-PROJECT-15K08980, KAKENHI-PROJECT-16K09334, KAKENHI-PROJECT-16K15420
[Journal Article] Add-on effects of fluvastatin in simeprevir/pegylated-interferon/ribavirin combination therapy for patients with genotype 1 hepatitis C virus infection: A randomized controlled study2017
- Author(s)
  5.Suda G, Ito J, Nagasaka A, Yamamoto Y, Furuya K, Okamoto M, Terashita K, Kobayashi T, Tsunematsu I, Yoshida J, Meguro T, Ohara M, Kawagishi N, Kimura M, Umemura M, Izumi T, Tsukuda Y, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N
- Journal Title
  
  Hepatology Research
  
  Volume: 48
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K08980
[Journal Article] Novel Treatment of Hepatitis C Virus Infection for Patients with Renal Impairment2016
- Author(s)
  Suda G, Ogawa K, Kimura M, Nakai M, Sho T, Morikawa K, Sakamoto N.
- Journal Title
  
  J Clin Transl Hepatol
  
  Volume: 4(4) Pages: 320-327
- DOI
  10.14218/jcth.2016.00032
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26461021, KAKENHI-PROJECT-15K08980, KAKENHI-PROJECT-16K09334
[Journal Article] Prevalence and characteristics of naturally occurring sofosbuvir resistance-associated variants in patients with hepatitis C virus genotype 1b infection2016
- Author(s)
  Ito J, Suda G, Yamamoto Y, Nagasaka A, Furuya K, Kumagai K, Kikuchi H, Miyagishima T, Kobayashi T, Kimura M, Yamasaki K, Umemura M, Izumi T, Tsunematsu S, Sato F, Tsukuda Y, Terashita K, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto
- Journal Title
  
  Hepatol Res
  
  Volume: in press Issue: 13 Pages: 1294-1303
- DOI
  10.1111/hepr.12685
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15K08980, KAKENHI-PROJECT-26670375, KAKENHI-PROJECT-26461021, KAKENHI-PROJECT-16K15420
[Journal Article] Anti-adipogenic and antiviral effects of l-carnitine on hepatitis C virus infection.2016
- Author(s)
  Tsukuda Y, Suda G, Tsunematsu S, Ito J, Sato F, Terashita K, Nakai M, Sho T, Maehara O, Shimazaki T, Kimura M, Morikawa K, Natsuizaka M, Ogawa K, Ohnishi S, Chuma M, Sakamoto N
- Journal Title
  
  J Med Virol
  
  Volume: 89 Issue: 5 Pages: 857-866
- DOI
  10.1002/jmv.24692
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-16H05282, KAKENHI-PROJECT-26460982, KAKENHI-PROJECT-26461021, KAKENHI-PROJECT-15K08943, KAKENHI-PROJECT-15K08980, KAKENHI-PROJECT-16K09334, KAKENHI-PROJECT-16K15420
[Journal Article] Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C.2016
- Author(s)
  Suda G, Kudo M, Nagasaka A, Furuya K, Yamamoto Y, Kobayashi T, Shinada K, Tateyama M, Konno J, Tsukuda Y, Yamasaki K, Kimura M, Umemura M, Izumi T, Tsunematsu S, Sato F, Terashita K, Nakai M, Horimoto H, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N
- Journal Title
  
  J Gastroenterol
  
  Volume: in press
- NAID
  120006313426
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K08980
[Journal Article] ZEB1 expression is associated with prognosis of intrahepatic cholangiocarcinoma2016
- Author(s)
  Terashita K, Chuma M, Hatanaka Y, Hatanaka K, Mitsuhashi T, Yokoo H, Ohmura T, Ishizu H, Muraoka S, Nagasaka A, Tsuji T, Yamamoto Y, Kurauchi N, Shimoyama N, Toyoda H, Kumada T, Kaneoka Y, Maeda A, Ogawa K, Natsuizaka M, Kamachi H, Kakisaka T, Kamiyama T, Taketomi A, Matsuno Y, Sakamoto N
- Journal Title
  
  J Clin Pathol
  
  Volume: in press Issue: 7 Pages: 593-599
- DOI
  10.1136/jclinpath-2015-203115
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K08980, KAKENHI-PROJECT-25460449, KAKENHI-PROJECT-24590674, KAKENHI-PROJECT-26670375, KAKENHI-PROJECT-26460982, KAKENHI-PROJECT-15K08943, KAKENHI-PROJECT-16K08684
[Journal Article] Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma2015
- Author(s)
  Tsunematsu S, Chuma M, Kamiyama T, Miyamoto N, Yabusaki S, Hatanaka K, Mitsuhashi T, Kamachi H, Yokoo H, Kakisaka T, Tsuruga Y, Orimo T, Wakayama K, Ito J, Sato F, Terashita K, Nakai M, Tsukuda Y, Sho T, Suda G, Morikawa K, Natsuizaka M, Nakanishi M, Ogawa K, Taketomi A, Matsuno Y, Sakamoto N
- Journal Title
  
  Abdom Imaging
  
  Volume: 40 Issue: 6 Pages: 1492-9
- DOI
  10.1007/s00261-015-0352-9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K08980, KAKENHI-PROJECT-26460982, KAKENHI-PROJECT-26461021
[Journal Article] Serum granulysin levels as a predictor of serious telaprevir-induced dermatological reactions.2015
- Author(s)
  Suda G, Yamamoto Y, Nagasaka A, Furuya K, Kudo M, Chuganji Y, Tsukuda Y, Tsunematsu S, Sato F, Terasita K, Nakai M, Horimoto H, Sho T, Natsuizaka M, Ogawa K, Ohnishi S, Chuma M, Fujita Y, Abe R, Taniguchi M, Nakagawa M, Asahina Y, Sakamoto N
- Journal Title
  
  Hepatol Res
  
  Volume: 印刷中 Issue: 8 Pages: 837-45
- DOI
  10.1111/hepr.12421
- NAID
  120005820706
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-24390185, KAKENHI-PROJECT-24590958, KAKENHI-PROJECT-24590960, KAKENHI-PROJECT-25293169, KAKENHI-PROJECT-25670366, KAKENHI-PROJECT-25860513, KAKENHI-PROJECT-26670375, KAKENHI-PROJECT-15K08980
[Journal Article] A pivotal role of Krüppel-like factor 5 in regulation of cancer stem-like cells in hepatocellular carcinoma.2015
- Author(s)
  Maehara O, Sato F, Natsuizaka M, Asano A, Kubota Y, Itoh J, Tsunematsu S, Terashita K, Tsukuda Y, Nakai M, Sho T, Suda G, Morikawa K, Ogawa K, Chuma M, Nakagawa K, Ohnishi S, Komatsu Y, Whelan KA, Nakagawa H, Takeda H, Sakamoto N.
- Journal Title
  
  Cancer Biol Ther
  
  Volume: 16 Issue: 10 Pages: 14531461-14531461
- DOI
  10.1080/15384047.2015.1070992
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-15K08943, KAKENHI-PROJECT-15K08980, KAKENHI-PROJECT-26460933, KAKENHI-PROJECT-26461021
[Presentation] 肝硬変患者に対するカルニチン製剤の有用性の検討2015
- Author(s)
  小川浩司,梅村真知子,出水孝章,伊藤淳,常松聖司,佐藤史幸,中井正人,荘拓也,須田剛生,森川賢一,坂本直哉.
- Organizer
  第117回日本消化器病学会北海道支部例会
- Place of Presentation
  札幌コンベンションセンター（北海道　札幌市）
- Year and Date
  2015-08-29
- Data Source
  KAKENHI-PROJECT-15K08980

1. 坂本直哉 (10334418)

# of Collaborated Projects: 2 results

# of Collaborated Products: 20 results
2. 須田剛生 (20447460)

# of Collaborated Projects: 2 results

# of Collaborated Products: 20 results
3. ASAHINA Yasuhiro

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
4. MAEHARA Osamu

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
5. 森川賢一

# of Collaborated Projects: 0 results

# of Collaborated Products: 11 results
6. 荘拓也

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
7. 大西俊介

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
8. 夏井坂光輝

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Ogawa Koji 小川 浩司

koji ogawa 小川 浩司

Research Projects

Research Products

Co-Researchers

Glycan Modification Analysis as a Novel Diagnostic Marker and Therapeutic Target for Non-Alcoholic Fatty Liver DiseasePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Anti-Adipogenic and Antiviral Effects of L-Carnitine on Hepatitis C Virus InfectionPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Serum Angiopoietin-2 Predicts the Occurrence and Recurrence of Hepatocellular Carcinoma after Direct-Acting Antiviral Therapy for Hepatitis C2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation‐related hepatitis2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Changes in Serum Growth Factors during Resistance to Atezolizumab Plus Bevacizumab Treatment in Patients with Unresectable Hepatocellular Carcinoma2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Hepatitis C virus eradication by direct‐acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low‐density lipoprotein cholesterolemia without an increase in body weight2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Serum IL-1β predicts de novo hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C, not during anti-cancer/immunosuppressive therapy2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Changes in the estimated renal function after hepatitis C virus eradication with direct-acting antiviral agents: Impact of changes in skeletal muscle mass2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Baseline elevated serum angiopoietin-2 predicts long-term non-regression of liver fibrosis after direct-acting antiviral therapy for hepatitis C2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Characteristics and Lenvatinib Treatment Response of Unresectable Hepatocellular Carcinoma with Iso-High Intensity in the Hepatobiliary Phase of EOB-MRI2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Possible correlation between increased serum free carnitine levels and increased skeletal muscle mass following HCV eradication by direct acting antivirals2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Serum fatty acid-binding protein 5 is a significant factor in hepatocellular carcinoma progression independent of tissue expression level2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Time-dependent changes in the seroprevalence of COVID-19 in asymptomatic liver disease outpatients in an area in Japan undergoing a second wave of COVID-192020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Analysis of the optimal psoas muscle mass index cut-off values, as measured by computed tomography, for the diagnosis of loss of skeletal muscle mass in Japanese people.2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Prevalence, clinical course, and predictive factors of immune checkpoint inhibitor monotherapy-associated hepatitis in Japan.2020

Author(s)

Journal Title

Ogawa Koji 小川浩司

koji ogawa 小川浩司

[Journal Article] A pivotal role of Krüppel-like factor 5 in regulation of cancer stem-like cells in hepatocellular carcinoma.2015